Catalyst
Slingshot members are tracking this event:
Janssen has entered into a Definitive Collaboration and License agreement with Bavarian Nordic to Develop Vaccine for Chronic HPV Infections
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 18, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hpv, Collaboration, Mva-bn, Advac
